BNT162b2 boosted neutralizing antibody titers after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination

被引：0

作者：

Hammerschmidt, S. I. ^{[1
]}

Barros-Martins, J. ^{[1
]}

Cossmann, A. ^{[2
]}

Ramos, G. Morillas ^{[2
]}

Stankow, M. V. ^{[2
]}

Odak, I. ^{[1
]}

Dopfer-Jablonka, A. ^{[2
,3
]}

Hetzel, L. ^{[2
]}

Koehler, M. ^{[1
]}

Patzer, G. ^{[1
]}

Binz, C. ^{[1
]}

Ritter, C. ^{[1
]}

Friedrichsen, M. ^{[1
]}

Schultze-Florey, C. ^{[1
,4
]}

Ravens, I. ^{[1
]}

Willenzon, S. ^{[1
]}

Bubke, A. ^{[1
]}

Ristenpart, J. ^{[1
]}

Janssen, A. ^{[1
]}

Ssebyatika, G. ^{[5
]}

Kraehling, V. ^{[6
,7
]}

Bernhardt, G. ^{[1
]}

Hoffmann, M. ^{[8
,9
]}

Poehlmann, S. ^{[8
,9
]}

Krey, T. ^{[5
,10
]}

Bosnjak, B. ^{[1
]}

Foester, R. ^{[1
,3
,11
]}

Behrens, G. M. N. ^{[2
,3
,12
]}

机构：

[1] Hannover Med Sch, Inst Immunol, Hannover, Germany

[2] Hannover Med Sch, Dept Rheumatol & Immunol, Hannover, Germany

[3] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany

[4] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[5] Univ Lubeck, Inst Biochem, Lubeck, Germany

[6] Philipps Univ Marburg, Inst Virol, Marburg, Germany

[7] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Marburg, Germany

[8] German Primate Ctr, Infect Biol Unit, Gottingen, Germany

[9] Georg August Univ Gottingen, Fac Biol & Psychol, Hannover, Germany

[10] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig & Partner Site, Hamburg, Germany

[11] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany

[12] Ctr Individualized Infect Med CiiM, Hannover, Germany

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P 005

引用

页码：154 / 155

页数：2

共 50 条

[41] Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Hermosilla, Eduardo
Coma, Ermengol
Xie, Junqing
Feng, Shuo
Cabezas, Carmen
Mendez-Boo, Leonardo
Fina, Francesc
Ballo, Elisabet
Martinez, Montserrat
Medina-Peralta, Manuel
Argimon, Josep Maria
Prieto-Alhambra, Daniel
NATURE COMMUNICATIONS, 2022, 13 (01)
[42] Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination
Yoo, Jaeeun
Kim, Younjeong
Cha, Yu Mi
Lee, Jaewoong
Jeong, Yeon Jeong
Kim, Si-Hyun
Maragakis, Lisa L.
Lee, Seungok
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (10) : 1537 - 1543
[43] Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Shrotri, Madhumita
Navaratnam, Annalan M. D.
Nguyen, Vincent
Byrne, Thomas
Geismar, Cyril
Fragaszy, Ellen
Beale, Sarah
Fong, Wing Lam Erica
Patel, Parth
Kovar, Jana
Hayward, Andrew C.
Aldridge, Robert W.
LANCET, 2021, 398 (10298): : 385 - 387
[44] SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
Behrens, Georg M. N.
Cossmann, Anne
Stankov, Metodi V.
Nehlmeier, Inga
Kempf, Amy
Hoffmann, Markus
Poehlmann, Stefan
LANCET, 2021, 398 (10305): : 1041 - 1042
[45] A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen
Baek, Yae Jee
Kim, Woo-Joong
Ko, Jae-Hoon
Lee, Youn-Jung
Ahn, Jin Young
Kim, Jung Ho
Jang, Ho Cheol
Jeong, Hye Won
Kim, Yong Chan
Park, Yoon Soo
Kim, Sung -Han
Peck, Kyong Ran
Shin, Eui-Cheol
Choi, Jun Yong
VACCINE, 2023, 41 (10) : 1694 - 1702
[46] Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients
van Dam, P. A.
Debie, Y.
Teuwen, L.
Verbruggen, L.
Vanhoutte, G.
Peeters, B.
Croes, L.
Vulsteke, C.
Anguille, S.
Vandamme, T.
Peeters, M.
ESMO OPEN, 2022, 7 (02)
[47] More on Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
Tovani-Palone, Marcos R.
Patil, Shankargouda
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (06): : 576 - 576
[48] Myocarditis After BNT162b2 and mRNA-1273 Vaccination
Larson, Kathryn F.
Ammirati, Enrico
Adler, Eric D.
Cooper, Leslie T., Jr.
Hong, Kimberly N.
Saponara, Gianluigi
Couri, Daniel
Cereda, Alberto
Procopio, Antonio
Cavalotti, Cristina
Oliva, Fabrizio
Sanna, Tommaso
Ciconte, Vincenzo Antonio
Onyango, George
Holmes, David R.
Borgeson, Daniel D.
CIRCULATION, 2021, 144 (06) : 506 - 508
[49] BNT162b2 COVID-19 vaccine
不详
AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 57 - 58
[50] Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
Bauernfeind, Stilla
Salzberger, Bernd
Hitzenbichler, Florian
Scigala, Karolina
Einhauser, Sebastian
Wagner, Ralf
Gessner, Andre
Koestler, Josef
Peterhoff, David
VACCINES, 2021, 9 (10)

← 1 2 3 4 5 →